Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2025 Earnings Call Transcript
Operator: Good afternoon. My name is Sherry, and I will be your conference call operator today. [Operator Instructions] As a reminder, this call is being recorded.
Puma Biotechnology Inc. (PBYI)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 1,829,213 | $5,414,470 | +5% | 0.01% |
| 2. | Millennium Management Israel Englander | 1,385,194 | $4,100,174 | -27% | 0% |
| 3. | D E Shaw D. E. Shaw | 571,665 | $1,692,128 | +157% | 0% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 358,621 | $1,061,518 | 0% | |
| 5. | Eversept Partners Kamran Moghtaderi | 275,788 | $816,332 | -73% | 0.08% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $82.49 | 28 | $2,309.72 | 30 | 2014-04-11 | Filing | |
| $87.35 | 2 | $174.70 | 2 | 2014-04-09 | Filing | |
| $38.92 | 22,549 | $877,607.08 | 5,686,668 | 2013-11-08 | Filing | |
| $39.60 | 280,700 | $11,115,720.00 | 5,664,119 | 2013-11-05 | Filing | |
| $40.08 | 54,200 | $2,172,336.00 | 5,383,419 | 2013-10-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.40 | 10,800 | $36,720.00 | 43,550 | 2025-06-13 | Filing | |
| $3.39 | 8,100 | $27,459.00 | 94,958 | 2025-06-13 | Filing | |
| $3.40 | 27,000 | $91,800.00 | 27,000 | 2025-06-13 | Filing | |
| $3.40 | 22,000 | $74,800.00 | 53,322 | 2025-06-13 | Filing | |
| $3.40 | 11,610 | $39,474.00 | 75,390 | 2025-06-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,940,052 | $11,662,554 | 7.78% | |
| 2. | 3,847,368 | $11,388,209 | 0% | |
| 3. | 3,669,263 | $10,861,018 | 0% | |
| 4. | 1,149,660 | $3,402,994 | 0% | |
| 5. | 955,456 | $2,828,529 | 0% |
News See All
10 Best Short-Term Stocks To Buy Right Now
Thrilling highs, daunting lows, and the energized chase after the next big opportunity – this thoroughly defines the current stock market.
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2024 Earnings Call Transcript
Operator: Good afternoon. My name is Darrell and I will be your conference call operator today. At this time, all participants are in a listen-only mode.
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q3 2024 Earnings Call Transcript
Operator: Good afternoon. My name is Rob, and I'll be your conference call operator today. At this time, all participants are in listen-only mode.
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q2 2024 Earnings Call Transcript
Operator: Good afternoon. My name is Diego and I will be your conference call operator today. [Operator Instructions] As a reminder, this conference call is being recorded.
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript
Puma Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.16.
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2023 Earnings Call Transcript
Puma Biotechnology, Inc. misses on earnings expectations. Reported EPS is $0.26 EPS, expectations were $0.37. Puma Biotechnology, Inc.
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q3 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Camilla, and I will be your conference call operator today. [Operator Instructions] As a reminder, this call is being recorded.
5 Best Quality Penny Stocks to Buy
Chimerix, Inc. (NASDAQ:CMRX) is working on treatments for fatal diseases. Chimerix, Inc.
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q2 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Victoria, and I will be your conference call operator today. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
